Lixte Biotechnology Holdings Inc (OTCMKTS:LIXT) shares rose 8.5% on Tuesday . The company traded as high as $0.72 and last traded at $0.70, approximately 8,400 shares were traded during mid-day trading. An increase of 118% from the average daily volume of 3,856 shares. The stock had previously closed at $0.65.

The stock’s fifty day moving average is $0.77 and its two-hundred day moving average is $1.03.

About Lixte Biotechnology (OTCMKTS:LIXT)

Lixte Biotechnology Holdings, Inc operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primary focuses on developing various treatments for human cancers and other non-malignant diseases, including vascular diseases, such as heart attacks and strokes, and diabetes, as well as genetic diseases comprising Gaucher's disease; and depression and post-traumatic stress syndrome.

Featured Story: S&P 500 Index

Receive News & Ratings for Lixte Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lixte Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.